The effect of fixed oil and water extracts of Nigella sativa on sickle cells: An in vitro studya

Singapore Medical Journal

Volumn 51, Issue 3, 2010, Pages 230-234

  Ibraheem, N K ^a   Ahmed, J H ^b   Hassan, M K ^b  

^a UNIVERSITY OF BASRAH   (Iraq)

^b Department of Pharmacology ^*

Author keywords

Antioxidant; Antisickling; Fixed oil extract; Nigella sativa

Indexed keywords

HEPARIN; NIGELLA SATIVA EXTRACT; OIL; OXYGEN; SODIUM CHLORIDE; WATER;

ADOLESCENT; ADULT; ARTICLE; BLACK CUMIN; BLOOD SAMPLING; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DEOXYGENATION; ERYTHROCYTE SHAPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; PRESCHOOL CHILD; SCHOOL CHILD; SICKLE CELL ANEMIA; TREATMENT OUTCOME; VENOUS BLOOD;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTIOXIDANTS; ANTISICKLING AGENTS; CHILD; CONFIDENCE INTERVALS; HUMANS; MIDDLE AGED; NIGELLA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS; PLANT OILS; WATER; YOUNG ADULT;

EID: 77951899893     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J 2003; 9:45-54.
2. Ohnishi ST, Horiuchi KY, Horiuch K, Jurman ME, Sadanaga KK. Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells. Pharmacology 1986; 32:248-56.
3. el-Hazmi MA, Warsy AS, al-Fawaz I, et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematol 1996; 96:221-6.
4. Orringer EP, Blythe DSB, Johnson AE, et al. Effect of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and patients with sickle cell anemia. Blood 1991; 78:212-6.
5. Agil A, Sandrzadeh SM. Hydoxyurea protects erythrocytes against oxidative damage. Redox Rep 2000; 5:29-34.
6. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14:323-8.
7. Abdel-Wahhab MA, Aly SE. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol 2005; 25:218-23.
8. Boskabady MH, Shafei MN, Parsaee H. Effects of aqueous and macerated extracts from Nigella sativa on guinea pig isolated heart activity. Pharmazie 2005; 60:943-8.
9. Ohnishi ST. Inhibition of the in vitro formation of irreversibly sickled cells by cepharanthine. Br J Haematol 1983; 55:665-71.
10. de Araujo JT, Nero GS. Piracetam and acetamide in sickle-cell disease. Lancet 1977; 2:411.
11. Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seeds (nigella sativa L.). J Pharm Biomed Anal 1999; 19:757-62.
12. Ahmed JH, Al-Diwan MS, Jawad AM. Effect of methoxyverapamil, diltiazem, morphine and their combination on the formation of irreversibly sickled cells: an in vitro study. East Mediterr Health J 1997; 3:301-9.
13. Aqel MB. The calcium antagonistic effect of the volatile oil of nigella sativa seeds. Dirasat 1992; 19B:119-32.
14. Gilani AH, Aziz N, Khurram IM, Chuadhary KS, Iqbal A. Bronchodilator, spasmolytic and calcium antagonistic activities of nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. J Pak Med Assoc 2001; 51:115-20.
15. Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995; 61:33-6.
16. Kanter M, Demir H, Karakaya C, Ozbek H. Gastroprotective activity of nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol 2005; 11:6662-6.
17. Ohnishi ST, Ohnishi T. In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes. J Nutr 2001; 131:1085-92.
18. Prasad AS. Zinc deficiency in patients with sickle cell disease. Am J Clin Nutr 2002; 75:181-2.
19. Gupta VL, Chaubey BS. Efficacy of zinc therapy in prevention of crises in sickle cell anemia: a double blind, randomized controlled clinical trial. J Assoc Physician India 1995; 43:467-9.
20. Zago MP, Oteiza PI. The antioxidant properties of zinc: interaction with iron and antioxidants. Free Radic Biol Med 2001; 31:266-79.
21. Abi Berger. What does zinc do? BMJ 2002; 325:1062.
22. Zaoui A, Cherrah Y, Mahassini N, et al. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 2002; 9:69-74.
23. Vahdati-Mashhadian N, Rakhshndeh H, Omidi A. An investigation on LD50 and subacute hepatic toxicity of Nigella sativa seed extracts in mice. Pharmazie 2005; 60:544-7.